| Followers | 836 |
| Posts | 44321 |
| Boards Moderated | 12 |
| Alias Born | 06/20/2009 |
Monday, June 19, 2023 5:39:00 PM
https://www.prnewswire.com/news-releases/therapeutic-solutions-international-prepares-to-apply-for-emergency-use-authorization-eua-for-its-fda-phase-iii-covid-19-stem-cell-therapy-jadicell-301355728.html
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171607031&txt2find=Ongoing
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171473628&txt2find=Ongoing
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171194946&txt2find=blanks
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171185893&txt2find=Ongoing
Dixon knew there was NO Ongoing Phase 3 trial @ least we know why NOW
GHS https://www.otcmarkets.com/filing/html?id=16088583&guid=A77-kWaHY1NAB3h#ex99-1_htm
USE OF PROCEEDS
We will not receive any proceeds from the sale of the common stock by the selling stockholders.
The Company will retain broad discretion over the use of the net proceeds from the sale of the securities to purchaser. We currently intend to use the net proceeds for working capital, capital expenditures, extinguishment of debt or other liabilities, and general corporate purposes. We may also use a portion of the net proceeds to invest in or acquire businesses or technologies that we believe are complementary to our own, although we have no current commitments or binding agreements with respect to any acquisitions as of the date of this prospectus.
Dixon knowing NO Phase3 trial while over the last several months of continuously stating & PRing Ongoing appears to be now verified by recent filings[/color]
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171570775&txt2find=DTC
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171565486

